Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 41.00
Ask: 43.00
Change: 1.00 (2.44%)
Spread: 2.00 (4.878%)
Open: 41.00
High: 42.00
Low: 41.00
Prev. Close: 41.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio news - first Portuguese spin out

7 Aug 2018 07:00

RNS Number : 9417W
Frontier IP Group plc
07 August 2018
 

RNS REACH / RNS

AIM: FIPP

7 August 2018

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Portfolio news - first Portuguese spin out developing novel technologies to print electronics onto paper

 

Frontier IP, which specialises in commercialising university intellectual property, is delighted to announce its first Portuguese spin out NTPE¹ (the "Company"), in which it is taking a 31.8 per cent stake.

 

NTPE is developing novel technology called Paper-E to print electronic circuits, sensors and semiconductors onto any cellulose-based paper and is a result of the Group's formal relationship with the Universidade Nova de Lisboa Faculty of Science and Technology ("FCT NOVA").

 

The technology replaces the silicon used in electronics with eco-friendly metal oxides and cellulose, to create "inks" that can be used in specially adapted printers and printing technologies, such as ink-jet heads. It has been developed by a research team led by Professors Rodrigo Martins and Elvira Fortunato from FCT Nova. NTPE will develop and commercialise its work.

 

There is a huge range of industrial applications for the technology, including paper-based diagnostic kits, smart packaging, logistics, and many others.

 

Because it is possible to store data in the cellulose, there are potential applications in fraud prevention - for example, to replace microchips with electronic pages in passports and other identity documents which need to be tracked.

 

Non-governmental organisations in low and middle-income countries are keen to explore the technology for use in real time lab-on-paper diagnostic solutions. This is because it does not need a power source and results can be shared via mobile phones. The technology can also produce disposable smart electronic interfaces for near field and Radio-frequency identification, RFID, communications.

 

The technology has been developed within a research group from the materials department of FCT NOVA, national scientific research centre Cenimat and the Centre of Excellence in Microelectronics, Optoelectronics and Processes.

 

They bring together more than 65 researchers dedicated to new approaches in electronic materials and applying them to build novel electronic devices and systems. Cenimat collaborates with companies and research organisations such as Samsung, Merck, ETRI, Flexenable, Osram, LG, Solvay, Eurocat, the Navigator Company, Clara Saúde, INCM, and others.

 

The research team was shortlisted by the European Patent Office ("EPO") in the Research category of its Inventor of the Year Awards 2016.

 

At the time, the then EPO president Benoît Battistelli said: "The paper-based microchips developed by Elvira Fortunato and her team have the potential to bring smart computer technology to entirely new areas of daily life."

 

NTPE has been incorporated to develop and commercialise their work.

 

Frontier IP aims to be the leading commercial partner to Portuguese universities. As well as FCT NOVA, the company also has a range of formal and informal relationships with local universities and companies.

 

Frontier IP Chief Executive Officer Neil Crabb said: "We're very pleased to take a material stake in a company developing such ground-breaking technology. Paper-E has already attracted strong interest from a wide range of potential partners."

 

Professor Rodrigo Martins said: "From dreams to reality: this has been such a great journey to develop new eco-sustainable products using Paper-E capable of revolutionising the market for a broad range of existing and emerging fields. FCT NOVA and Frontier IP are on the frontline of commercialising Portuguese technology."

 

¹The Company is incorporated in Portugal under the full name of: NTPE Research, Development and Marketing of Transistors and Electronic Paper Biosensors.

 

 

 

ENQUIRIES

 

Frontier IP Group Plc

T: 0131 240 1251

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

 

M: 07464 546 025

Cenkos Securities plc (Nominated Adviser and Joint Broker)

T: 0131 220 6939

Neil McDonald / Beth McKiernan

Peterhouse Corporate Finance Limited (Joint Broker)

T: 020 7469 0935

Lucy Williams

Kreab (Financial PR)

T: 020 7074 1800

Robert Speed / Matthew Jervois

 

NOTES TO EDITORS

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEAEPKESNPEFF
Date   Source Headline
28th Jul 20205:22 pmRNSHolding(s) in Company
22nd Jul 202012:50 pmRNSHolding(s) in Company
21st Jul 20209:05 amRNSSecond Price Monitoring Extn
21st Jul 20209:00 amRNSPrice Monitoring Extension
21st Jul 20207:00 amRNSResult of Capital Raising
20th Jul 20204:37 pmRNSPrimaryBid.com Offer
20th Jul 20204:35 pmRNSProposed Capital Raising of a minimum of £2m
20th Jul 20202:00 pmRNSCambridge Raman Imaging completes £250,000 funding
14th Jul 20207:00 amRNSAquaInSilico wins grant to commercialise software
13th Jul 20207:00 amRNSPulsiv demonstrates strong progress
7th Jul 20207:00 amRNSCelerum supports development for PlanSea Solutions
6th Jul 20207:00 amRNSBosch collaboration with Fieldwork
30th Jun 20205:00 pmRNSTotal Voting Rights
23rd Jun 20207:00 amRNSThe Vaccine Group: strong COVID-19 progress
17th Jun 20207:00 amRNSCambridge & FIPP collaborate to tackle gum disease
28th May 20207:10 amRNSPortfolio news: Access to Elute's Patent Reader
28th May 20207:00 amRNSExercise of Options and Total Voting Rights
26th May 20207:00 amRNSPortfolio news – Exscientia raises $60 million
7th May 20207:00 amRNSExscientia and SRI International collaborate
1st May 20207:00 amRNSPortfolio news – Molendotech raises £425,000
15th Apr 20207:00 amRNSPortfolio news – Pulsiv Solar awarded patent
9th Apr 20207:00 amRNSPortfolio news: Alusid launches luxury Block range
6th Apr 202012:01 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSExscientia announces joint initiative re COVID-19
30th Mar 20204:40 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSElute Intelligence’s AI to back COVID-19 research
26th Mar 20207:00 amRNSPortfolio news: new portfolio company AquaInSilico
25th Mar 20207:00 amRNSUnaudited Half Year Results
19th Mar 20207:00 amRNSFrontier partners University of Lisbon competition
17th Mar 20203:15 pmRNSNotice of interim results
13th Mar 20207:00 amRNSPortfolio news – The Vaccine Group Update
12th Mar 202011:05 amRNSSecond Price Monitoring Extn
12th Mar 202011:00 amRNSPrice Monitoring Extension
19th Feb 202012:37 pmRNSHolding(s) in Company
17th Feb 20207:00 amRNSCRIL wins EUR140,000 EU Graphene Flagship funding
12th Feb 20207:00 amRNSPortfolio news - FIPP increases stake in Celerum
31st Jan 20207:00 amRNSPortfolio news - Exscientia
20th Jan 20207:00 amRNSPortfolio news - The Vaccine Group raises £680,000
16th Jan 20203:28 pmRNSHolding(s) in Company
14th Jan 20207:00 amRNSFieldwork Robotics secures first equity funding
10th Jan 20207:00 amRNSExscientia enters collaboration with Bayer AG
31st Dec 20191:00 pmRNSTotal Voting Rights
16th Dec 201910:36 amRNSExercise of Options and Issue of Equity
11th Dec 20196:03 pmRNSHolding(s) in Company
9th Dec 20193:25 pmRNSHolding(s) in Company
9th Dec 20193:21 pmRNSHolding(s) in Company
9th Dec 20192:08 pmRNSHolding(s) in Company
9th Dec 20199:46 amRNSHolding(s) in Company
9th Dec 20197:00 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.